REPAIRING MS – The Quest to Rebuild Myelin
Very interesting Podcast by Dr. Barry Singer, MD – Neurology The quest to repair the damage caused by multiple sclerosis…
Neural stem cell therapy repairs myelin in MS mouse model: Study
Research suggests potential new way to treat progressive forms of disease by Steve Bryson, PhD | July 11, 2025 Treatment…
Stuart Schlossman
Reversing MS Symptoms? The Power of Remyelination – video with Aaron Boster, MD
Can your brain repair itself after MS damage? In this video, Dr. Aaron Boster dives into the groundbreaking field of…
Stuart Schlossman
Demyelination and Demyelinating Disease
Medically reviewed by Susan W. Lee, DO — Written by Heather Hobbs — Updated on January 29, 2025 Demyelination refers…
Stuart Schlossman
MS and the Myelin Sheath: Demyelination Causes and Treatments
Medically reviewed by Barry Singer, M.D. / Written by Daniel Bukszpan What role does myelin damage play in the MS disease course?…
Stuart Schlossman
International Workshop Focuses on Aging with Multiple Sclerosis
May 28, 2024 Almost half of all people living with MS today are 55 years of age or older, and…
Stuart Schlossman
Read about the Pathways to CURES for MS
We’ve Never Been Closer The National Multiple Sclerosis Society is bringing the world together to cure MS for every single person —…
Stuart Schlossman
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNS
Tal Ganz, Omri Zveik, Nina Fainstein, Marva Lachish, Ariel Rechtman, Lihi Sofer, Livnat Brill, Tamir Ben-Hur, Adi Vaknin-Dembinsky First published: 23 August 2023 https://doi.org/10.1002/glia.24453 Tal Ganz and…
Stuart Schlossman
Myelin Repair, Progressive MS, Exercise, and Other Research News
October 22, 2021 Myelin repair strategies, progressive MS, exercise, and other promising avenues took center stage at the virtual European…
Stuart Schlossman
PIPE-307, Aiming to Restore Myelin, Found Safe in Phase 1 Trial
PIPE-307, an investigational myelin-restoring medication being developed by Pipeline Therapeutics for the treatment of multiple sclerosis (MS), appears to be…
Stuart Schlossman
